# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-277564
Filing Date
2025-11-12
Accepted
2025-11-12 16:09:02
Documents
80
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lyra-20250930.htm iXBRL | 10-Q | 3036893
2 | EX-31.1 | lyra-ex31_1.htm | EX-31.1 | 17979
3 | EX-31.2 | lyra-ex31_2.htm | EX-31.2 | 17973
4 | EX-32.1 | lyra-ex32_1.htm | EX-32.1 | 10351
5 | EX-32.2 | lyra-ex32_2.htm | EX-32.2 | 10340
| Complete submission text file | 0001193125-25-277564.txt |  | 11058175

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | lyra-20250930.xsd | EX-101.SCH | 1416206
83 | EXTRACTED XBRL INSTANCE DOCUMENT | lyra-20250930_htm.xml | XML | 1950214

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39273 | Film No.: 251472747
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)